| Financial Year |
March 31 2023 |
| Monetary Funds |
1,827,031,178.42 |
| Held-for-trading Financial Assets |
328,507,952.73 |
| Notes Receivable |
812,250.00 |
| Accounts Receivable |
167,369,936.73 |
| Advances to Suppliers |
44,533,933.66 |
| Other Receivables |
20,867,779.99 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
437,796,962.76 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
5,188,512.27 |
| Other Current Assets |
260,399,431.78 |
| Total Current Assets |
3,092,507,938.34 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
6,936,380.15 |
| Long-term Equity Investment |
50,446,605.95 |
| Investment Properties |
-- |
| Fixed Assetes |
1,174,569,661.61 |
| Under-construction Projects |
565,532,865.18 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
235,495,270.59 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
19,337,849.19 |
| Deferred Income Tax Assets |
27,626,496.56 |
| Other Non-Current Assets |
420,128,758.81 |
| Sub-Total of Non-Current Assets |
3,502,776,701.34 |
| Total Assets |
6,595,284,639.68 |
| Short-Term Loans |
935,695,369.73 |
| Trading Financial liabilities |
1,888,050.00 |
| Notes Payable |
60,225,930.53 |
| Accounts Payable |
349,969,252.88 |
| Accounts Received In Advance |
3,265,817.61 |
| Employee Compensation Payable |
44,976,975.59 |
| Taxes Payable |
92,721,215.77 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
20,596,896.73 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
179,647,696.18 |
| Other Current Liabilities |
1,824,685.12 |
| Sub-Total of Current Liabilities |
1,747,761,555.37 |
| Long-term Loans |
749,700,344.86 |
| Bonds Payable |
114,597,191.89 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
174,528,470.19 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
2,000,625,987.22 |
| Total Liabilities |
3,748,387,542.59 |
| Paid-In Capital(Or Share Stock) |
239,243,253.00 |
| Capital Surplus |
1,252,933,046.26 |
| Surplus Reserve |
61,738,747.03 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
1,243,009,704.81 |
| Minority Stockholder's Interest |
16,947.42 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,846,880,149.67 |
| Owner's Equity（Stockholder's Equity） |
2,846,897,097.09 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
6,595,284,639.68 |
